Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

A Phase 1, Open-Label, Multicenter Study of HMPL-306 in Advanced Hematological Malignancies with Isocitrate Dehydrogenase (IDH) Mutations

Anu Doraiswamy, Vijayvel Jayaprakash, Marek Kania, Marjo Hahka-Kemppinen, Zhao Yang, Mark Rudinski, Farhad Ravandi

Blood (2021) 138 (Supplement 1): 4438.

https://doi.org/10.1182/blood-2021-145636

Published: 2021

Journal Articles

Association between Insufficient Interleukin-6 (IL-6) Inhibition and Worsening Outcomes in COVID-19 and Idiopathic Multicentric Castleman Disease (iMCD), and a Mathematical Model to Predict Optimal Dosing to Completely Block IL-6 Activity

Jean-Francois Rossi, Hao-Chun Chiang, Zhao-Yang Lu, Kalle Levon, Frits van Rhee, Karan Kanhai, David C Fajgenbaum, Bernard Klein

Blood (2021) 138 (Supplement 1): 4004.

https://doi.org/10.1182/blood-2021-150433

Published: 2021

Journal Articles

A Phase 1 First in Human (FIH) Study of AMG 701, an Anti-B-Cell Maturation Antigen (BCMA) Half-Life Extended (HLE) BiTE ® (bispecific T-cell engager) Molecule, in Relapsed/Refractory (RR) Multiple Myeloma (MM)

Blood (2020) 136 (Supplement 1): 28–29.

https://doi.org/10.1182/blood-2020-134063

Published: 2020

Journal Articles

Carfilzomib vs bortezomib in patients with multiple myeloma and renal failure: a subgroup analysis of ENDEAVOR

Meletios Dimopoulos, David Siegel, Darrell J. White, Ralph Boccia, Karim S. Iskander, Zhao Yang, Amy S. Kimball, Khalid Mezzi, Heinz Ludwig, Ruben Niesvizky

Blood (2019) 133 (2): 147–155.

https://doi.org/10.1182/blood-2018-06-860015

Published: 2019

Includes: Supplemental data

Journal Articles

Salvage Therapy Outcomes in a Historical Cohort of Patients with Relapsed or Refractory Acute Myeloid Leukemia

Farhad Ravandi, MD, Sherry A. Pierce, BSN, BA, Guillermo Garcia-Manero, MD, Tapan M. Kadia, MD, Elias J. Jabbour, MD, Gautam Borthakur, MD, Courtney D. DiNardo, MD MSc, Naval G. Daver, MD, Nicholas J Short, MD, Yesid Alvarado, MD, Jorge E. Cortes, MD, Christopher Kim, PhD, Michael A Kelsh, PhD MPH, MA, Aaron Jacob Katz, PhD PharmD, Richard Williams, MBBS, PhD, Zhao Yang, Bhakti Mehta, MD MPH, Hagop M. Kantarjian, MD

Blood (2018) 132 (Supplement 1): 3985.

https://doi.org/10.1182/blood-2018-99-118380

Published: 2018

Journal Articles

A Phase 1 First-in-Human Study of AMG 330, an Anti-CD33 Bispecific T-Cell Engager (BiTE ® ) Antibody Construct, in Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)

Farhad Ravandi, MD, Anthony S. Stein, MD, Hagop M. Kantarjian, MD, Roland B. Walter, MD PhD MS, Peter Paschka, MD, Mojca Jongen-Lavrencic, MD PhD, Gert J. Ossenkoppele, MD PhD, Zhao Yang, Bhakti Mehta, Marion Subklewe, MD

Blood (2018) 132 (Supplement 1): 25.

https://doi.org/10.1182/blood-2018-99-109762

Published: 2018

Journal Articles

Subgroup Analysis of Patients with Biochemical or Symptomatic Relapse at the Time of Enrollment in the Endeavor Study

Philippe Moreau, David S Siegel, MD PhD, Hartmut Goldschmidt, MD, Ruben Niesvizky, MD, Sara Bringhen, MD, Robert Z Orlowski, MD PhD, Julie Blaedel, Zhao Yang, Meletios A Dimopoulos, MD

Blood (2018) 132 (Supplement 1): 3243.

https://doi.org/10.1182/blood-2018-99-112571

Published: 2018

Journal Articles

Carfilzomib in Relapsed or Refractory Multiple Myeloma Patients with Early or Late Relapse Following Prior Therapy: An Analysis of Overall Survival in Subgroups from the Randomized Phase 3 Aspire and Endeavor Trials

Maria-Victoria Mateos, MD PhD, Hartmut Goldschmidt, MD, Jesus F San-Miguel, MD PhD, Julie Blaedel, Mihaela Obreja, Zhao Yang, Zsolt Szabo, Xavier Leleu, MD PhD

Blood (2018) 132 (Supplement 1): 1964.

https://doi.org/10.1182/blood-2018-99-112189

Published: 2018

Journal Articles

A Phase 1b Study of Oprozomib with Dexamethasone or Pomalidomide and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma

Parameswaran Hari, MBBS, MD, Mark A. Schroeder, MD, James R Berenson, Andrzej Jakubowiak, MD PhD, Jonathan L Kaufman, MD, Peter M. Voorhees, MD, Hisaki Fujii, Zhao Yang, Francesco Galimi, MDPhD, Kenneth H. Shain, MD PhD

Blood (2018) 132 (Supplement 1): 803.

https://doi.org/10.1182/blood-2018-99-112610

Published: 2018

Journal Articles

Superior Efficacy of Carfilzomib and Dexamethasone (Kd56) Vs Bortezomib and Dexamethasone (Vd) in Multiple Myeloma (MM) Patients with Moderate or Serious Renal Failure: A Subgroup Analysis of the Phase 3 Endeavor Study

Meletios A. Dimopoulos, David Siegel, MD PhD, Darrell J. White, MD, Ralph V. Boccia, Zhao Yang, Amy S. Kimball, Karim Saad Iskander, Khalid Mezzi, MD MBA, Heinz Ludwig, MD, Ruben Niesvizky, MD

Blood (2017) 130 (Supplement 1): 1845.

https://doi.org/10.1182/blood.V130.Suppl_1.1845.1845

Published: 2017

Journal Articles

Clinical implications of plasma Epstein-Barr virus DNA in early-stage extranodal nasal-type NK/T-cell lymphoma patients receiving primary radiotherapy

Zhao-Yang Wang, Qing-Feng Liu, Hua Wang, Jing Jin, Wei-Hu Wang, Shu-Lian Wang, Yong-Wen Song, Yue-Ping Liu, Hui Fang, Hua Ren, Run-Ye Wu, Bo Chen, Xi-Mei Zhang, Ning-Ning Lu, Li-Qiang Zhou, Ye-Xiong Li

Blood (2012) 120 (10): 2003–2010.

https://doi.org/10.1182/blood-2012-06-435024

Published: 2012

Includes: Supplemental data

Journal Articles

Primary radiotherapy showed favorable outcome in treating extranodal nasal-type NK/T-cell lymphoma in children and adolescents

Zhao-Yang Wang, Ye-Xiong Li, Wei-Hu Wang, Jing Jin, Hua Wang, Yong-Wen Song, Qing-Feng Liu, Shu-Lian Wang, Yue-Ping Liu, Shu-Nan Qi, Hui Fang, Xin-Fan Liu, Zi-Hao Yu

Blood (2009) 114 (23): 4771–4776.

https://doi.org/10.1182/blood-2009-07-235853

Published: 2009

Journal Articles

Mobilization of Plasma Cells in Healthy Individuals Treated with G-CSF for Hematopoietic Stem Collection.

Anouk Caraux, Marion Larroque, Christophe Duperray, Zhao-Yang Lu, Jean-François Rossi, MD, PhD, Bernard Klein

Blood (2009) 114 (22): 3679.

https://doi.org/10.1182/blood.V114.22.3679.3679

Published: 2009

Journal Articles

Regulatory and Activated T Cells in Stem Cell Autografts Collected by Mobilization with High-Dose Cyclophosphamide and Granulocyte Colony Stimulating Factor.

Maud Condomines, Philippe Quittet, Zhao-Yang Lu, Laure Nadal, Pascal Latry, Ernesto Lopez, Marion Baudard, Jean-François Rossi, Karin Tarte, Bernard Klein

Blood (2005) 106 (11): 5216.

https://doi.org/10.1182/blood.V106.11.5216.5216

Published: 2005

Journal Articles

Kaposi’s Sarcoma-Associated Herpesvirus Is Not Detected With Immunosuppression in Multiple Myeloma

Karin Tarte, Sonja J. Olsen, Jean-François Rossi, Eric Legouffe, Zhao-Yang Lu, Michel Jourdan, Yuan Chang, Bernard Klein

Blood (1998) 92 (6): 2186–2188.

https://doi.org/10.1182/blood.V92.6.2186

Published: 1998

Journal Articles

Clinical-Grade Functional Dendritic Cells From Patients With Multiple Myeloma Are Not Infected With Kaposi's Sarcoma-Associated Herpesvirus

Karin Tarte, Sonja J. Olsen, Zhao Yang Lu, Eric Legouffe, Jean-François Rossi, Yuan Chang, Bernard Klein

Blood (1998) 91 (6): 1852–1857.

https://doi.org/10.1182/blood.V91.6.1852

Published: 1998

Journal Articles

Generation of Virtually Pure and Potentially Proliferating Dendritic Cells From Non-CD34 Apheresis Cells From Patients With Multiple Myeloma

Karin Tarte, Zhao Yang Lu, Genevieve Fiol, Eric Legouffe, Jean-François Rossi, Bernard Klein

Blood (1997) 90 (9): 3482–3495.

https://doi.org/10.1182/blood.V90.9.3482

Published: 1997

NARROW

A Phase 1, Open-Label, Multicenter Study of HMPL-306 in Advanced Hematological Malignancies with Isocitrate Dehydrogenase (IDH) Mutations

Association between Insufficient Interleukin-6 (IL-6) Inhibition and Worsening Outcomes in COVID-19 and Idiopathic Multicentric Castleman Disease (iMCD), and a Mathematical Model to Predict Optimal Dosing to Completely Block IL-6 Activity

A Phase 1 First in Human (FIH) Study of AMG 701, an Anti-B-Cell Maturation Antigen (BCMA) Half-Life Extended (HLE) BiTE ® (bispecific T-cell engager) Molecule, in Relapsed/Refractory (RR) Multiple Myeloma (MM)

Carfilzomib vs bortezomib in patients with multiple myeloma and renal failure: a subgroup analysis of ENDEAVOR

Salvage Therapy Outcomes in a Historical Cohort of Patients with Relapsed or Refractory Acute Myeloid Leukemia

A Phase 1 First-in-Human Study of AMG 330, an Anti-CD33 Bispecific T-Cell Engager (BiTE ® ) Antibody Construct, in Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)

Subgroup Analysis of Patients with Biochemical or Symptomatic Relapse at the Time of Enrollment in the Endeavor Study

Carfilzomib in Relapsed or Refractory Multiple Myeloma Patients with Early or Late Relapse Following Prior Therapy: An Analysis of Overall Survival in Subgroups from the Randomized Phase 3 Aspire and Endeavor Trials

A Phase 1b Study of Oprozomib with Dexamethasone or Pomalidomide and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma

Superior Efficacy of Carfilzomib and Dexamethasone (Kd56) Vs Bortezomib and Dexamethasone (Vd) in Multiple Myeloma (MM) Patients with Moderate or Serious Renal Failure: A Subgroup Analysis of the Phase 3 Endeavor Study

Clinical implications of plasma Epstein-Barr virus DNA in early-stage extranodal nasal-type NK/T-cell lymphoma patients receiving primary radiotherapy

Primary radiotherapy showed favorable outcome in treating extranodal nasal-type NK/T-cell lymphoma in children and adolescents

Mobilization of Plasma Cells in Healthy Individuals Treated with G-CSF for Hematopoietic Stem Collection.

Regulatory and Activated T Cells in Stem Cell Autografts Collected by Mobilization with High-Dose Cyclophosphamide and Granulocyte Colony Stimulating Factor.

Kaposi’s Sarcoma-Associated Herpesvirus Is Not Detected With Immunosuppression in Multiple Myeloma

Clinical-Grade Functional Dendritic Cells From Patients With Multiple Myeloma Are Not Infected With Kaposi's Sarcoma-Associated Herpesvirus

Generation of Virtually Pure and Potentially Proliferating Dendritic Cells From Non-CD34 Apheresis Cells From Patients With Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only